Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dmk Pharmaceuticals Corporation (DMKPQ)
:DMKPQ
Holding DMKPQ?
Track your performance easily
DMKPQ Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.62
Previous CloseN/A
Volume2.07K
Average Volume (3M)3.78K
Market Cap
$10.00
Enterprise ValueN/A
Total Cash (Recent Filing)$4.09M
Total Debt (Recent Filing)$3.07M
Price to Earnings (P/E)―
Beta-21.74
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-9.18
Shares Outstanding10,102,050
10 Day Avg. Volume4,023
30 Day Avg. Volume3,783
Standard Deviation0.83
R-Squared0.00717
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
DMKPQ FAQ
What was Dmk Pharmaceuticals Corporation’s price range in the past 12 months?
Dmk Pharmaceuticals Corporation lowest stock price was <$0.01 and its highest was $0.62 in the past 12 months.
What is Dmk Pharmaceuticals Corporation’s market cap?
Dmk Pharmaceuticals Corporation’s market cap is $10.00.
When is Dmk Pharmaceuticals Corporation’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Dmk Pharmaceuticals Corporation’s earnings last quarter?
Currently, no data Available
Is Dmk Pharmaceuticals Corporation overvalued?
According to Wall Street analysts Dmk Pharmaceuticals Corporation’s price is currently Overvalued.
Does Dmk Pharmaceuticals Corporation pay dividends?
Dmk Pharmaceuticals Corporation does not currently pay dividends.
What is Dmk Pharmaceuticals Corporation’s EPS estimate?
Dmk Pharmaceuticals Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dmk Pharmaceuticals Corporation have?
Dmk Pharmaceuticals Corporation has 10,102,050 shares outstanding.
What happened to Dmk Pharmaceuticals Corporation’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Dmk Pharmaceuticals Corporation?
Currently, no hedge funds are holding shares in DMKPQ
---
Company Description
Dmk Pharmaceuticals Corporation
Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development and sales of pharmaceutical, specialty biopharmaceutical and other drug products. It offers Symjepi product for allergy, respiratory, opioid overdose, and erectile dysfunction (ED), markets. The company was founded in June 2006 and is headquartered in San Diego, CA.
---
DMKPQ Earnings Call
Q1 2023
0:00 / 0:00
---
---